The two roles of FBP2 result in a reduction in the energy supply to the cancer cells, which provides an explanation for the frequent loss of FBP2 in STS and its potential as a therapeutic target (Huangyang et al., 2020). The gene discussed is FBP2; the disease is telomere syndrome.